Directory
>
Sunitha Reddy Nalla
Sunitha Reddy Nalla
Vice President, Regulatory Affairs | Karyopharm Therapeutics Inc.
Boston, Massachusetts, United States
Sunitha Reddy Nalla
Summary
Sunitha Reddy Nalla is a seasoned regulatory affairs executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Vice President of Regulatory Affairs at Karyopharm Therapeutics, she has a strong background in regulatory operations, quality assurance, and compliance with FDA regulations. Sunitha has held various leadership roles throughout her career, demonstrating her ability to navigate complex regulatory landscapes and drive successful product approvals. Her expertise spans clinical trials, document management systems, and standard operating procedures, making her a valuable asset in the life sciences sector. With a history of working in both corporate and consulting environments, she brings a unique perspective to her role. Sunitha's commitment to innovation and quality in regulatory practices positions her as a thought leader in her field.
Sunitha Reddy Nalla
Work Experience
Vice President, Regulatory Affairs at
Karyopharm Therapeutics Inc.
December 2019 - Present
Regulatory Affairs Operations at
Karyopharm Therapeutics Inc.
March 2018 - December 2019
Life Sciences at
Consultant
October 2017 - March 2018
Regulatory operations/Business Technology at
Sanofi
September 2013 - September 2017
Associate Director/ Head of Regulatory Operations at
AVEO Oncology
August 2011 - June 2013
Life Sciences at
Consultant
April 2010 - August 2011
Sr. Consultant at
Image Solutions, Inc.
June 2008 - April 2010
Regulatory Operations at
Vertex Pharmaceuticals
May 2006 - June 2008
Regulatory Operations at
Datafarm Inc
May 2004 - May 2006
Consultant at
Case Consulting
June 2001 - April 2004
Sr. Software Engineer at
Cascade Communicationsascendlucent Technologies
February 1996 - June 2001
Programmer /Analyst at
Delphi Internet Services
January 1995 - January 1996
SoftwareEngineer at
Smith Advanced Technology
January 1994 - January 1995
Frequently Asked Questions about Sunitha Reddy Nalla
What is Sunitha Reddy Nalla email address?
Sunitha Reddy Nalla's primary email address is ******@karyopharm.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sunitha Reddy Nalla work for?
Sunitha Reddy Nalla is a Vice President, Regulatory Affairs at Karyopharm Therapeutics Inc., a company specializing in Biological products, except diagnostic.
How can I directly contact Sunitha Reddy Nalla?
To contact Sunitha Reddy Nalla directly, you can use the email address ******@karyopharm.com. Complete contact information is available upon registration with Muraena.
Who is Sunitha Reddy Nalla?
Sunitha Reddy Nalla is a seasoned regulatory affairs executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Vice President of Regulatory Affairs at Karyopharm Therapeutics, she has a strong background in regulatory operations, quality assurance, and compliance with FDA regulations. Sunitha has held various leadership roles throughout her career, demonstrating her ability to navigate complex regulatory landscapes and drive successful product approvals. Her expertise spans clinical trials, document management systems, and standard operating procedures, making her a valuable asset in the life sciences sector. With a history of working in both corporate and consulting environments, she brings a unique perspective to her role. Sunitha's commitment to innovation and quality in regulatory practices positions her as a thought leader in her field.
Sunitha`s contact details
******@karyopharm.com
Colleagues
Vice President, Data Sciences
Independent Board Director
Lecturer, Graduate Program (Regulatory Affairs)
Vice President Research & Translational Medicine
Vice President, Business Operations and Corporate Affairs
Executive Director - Head of Medical Strategy Global Medical and Scientific Affairs
Vice President of Market Access
Vice President, Clinical Pharmacology
Vice President, Program Lead - Oncology
Vice President, Clinical Development - Myelofibrosis and MDS